Medray teams up with Rehabologym on neurological rehab push

Medray Laser & Technology has formed a strategic partnership with Rehabologym to expand neurological rehabilitation, education and technology integration. The collaboration makes Rehabologym an official Medray Ambassador Clinic and centers on therapies for patients with conditions including stroke, TBI, spinal cord injury and Parkinson’s disease.

Why it matters: - The partnership puts Medray’s therapeutic devices into a specialized neurological rehabilitation setting. - Rehabologym serves pediatric, adult and geriatric patients, so the collaboration could broaden clinical exposure for Medray’s technologies. - The agreement is designed to support patient outcomes, provider education and broader adoption of advanced rehabilitation tools.

What happened: - Medray Laser & Technology announced a strategic partnership with Rehabologym on June 11, 2026. - Rehabologym will operate as an official Medray Ambassador Clinic and collaborative rehabilitation partner. - The relationship is focused on neurological rehabilitation, technology integration, education and patient-centered care. - Medray plans to support Rehabologym’s efforts in mobility restoration, functional recovery and advanced therapeutic care.

The details: - Rehabologym is headquartered in Tarrytown, New York. - The center specializes in neurological occupational therapy, physical therapy, speech therapy and advanced rehabilitation methodologies. - Rehabologym treats patients with stroke, traumatic brain injury, spinal cord injury, Parkinson’s disease, multiple sclerosis, ALS and other neurological disorders. - The clinic uses Medray’s high-intensity laser therapy and Softshock shockwave therapy. - Rehabologym combines robotics, intensive therapy programs and evidence-based methods aimed at improving function, mobility, independence and quality of life. - The rehabilitation model includes customized evaluations, one-on-one therapy sessions, group programs, mobility and balance training, cognitive rehabilitation, caregiver support services, home exercise programming and robotic-assisted therapies. - Rehabologym has existing partnerships with universities, research organizations and rehabilitation leaders. - Medray says the partnership expands its reach into advanced rehabilitation markets and supports providers using regenerative and rehabilitation-focused technologies. - Medray’s product line includes Class IV laser and shockwave advanced regenerative therapy devices. - Medray’s announcement also points to U.S.-based support, ongoing education and a focus on quality. - Medray shared the announcement through its social channels, including LinkedIn, Instagram, Facebook and YouTube.

Between the lines: - The partnership gives Medray a clinical showcase for its devices inside a rehab center already positioned around neuro-robotic care. - Rehabologym gains a branded relationship that could help with education, awareness and access to new therapeutic tools. - The deal reflects a broader push in rehabilitation toward technology-assisted treatment and interdisciplinary care.

What's next: - Medray and Rehabologym plan to work on educational initiatives, awareness campaigns, clinical integration strategies and future collaboration opportunities. - The companies expect the partnership to create more opportunities for clinicians in occupational therapy, physical therapy, rehabilitation specialties and related healthcare fields. - The collaboration is likely to serve as a test case for how advanced regenerative technologies fit into neurological rehabilitation programs.

The bottom line: - Medray is using the Rehabologym partnership to deepen its presence in neurological rehab while Rehabologym adds a new technology partner tied to patient care innovation.